Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Long-term SARS-CoV-2 Asymptomatic Carriage in an Immunocompromised Host: Clinical, Immunological, and Virological Implications
Michele Spinicci, Alessio Mazzoni, Marco Coppi, et al.
Journal of Clinical Immunology (2022) Vol. 42, Iss. 7, pp. 1371-1378
Open Access | Times Cited: 16

Showing 16 citing articles:

Combination regimen of nirmatrelvir/ritonavir and molnupiravir for the treatment of persistent SARS-CoV-2 infection: A case report and a scoping review of the literature
Davide Marangoni, Roberta Maria Antonello, Marco Coppi, et al.
International Journal of Infectious Diseases (2023) Vol. 133, pp. 53-56
Open Access | Times Cited: 27
Virus Evolution in Prolonged Infections of Immunocompromised Individuals
Zoe Raglow, Adam S. Lauring
Clinical Chemistry (2025) Vol. 71, Iss. 1, pp. 109-118
Closed Access
Successful use of nirmatrelvir/ritonavir in immunocompromised patients with persistent and/or relapsing COVID-19
Lucia Graziani, Leonardo Gori, Tommaso Manciulli, et al.
Journal of Antimicrobial Chemotherapy (2022) Vol. 78, Iss. 2, pp. 555-558
Open Access | Times Cited: 18
Antiviral combination regimens as rescue therapy in immunocompromised hosts with persistent COVID-19
Roberta Maria Antonello, Davide Marangoni, Filippo Ducci, et al.
Journal of Chemotherapy (2024), pp. 1-5
Closed Access | Times Cited: 2
The Four Ws of the Fourth Dose COVID-19 Vaccines: Why, Who, When and What
Ka-Wa Khong, Ruiqi Zhang, Ivan Fan‐Ngai Hung
Vaccines (2022) Vol. 10, Iss. 11, pp. 1924-1924
Open Access | Times Cited: 11
A multinational, phase 2, randomised, adaptive protocol to evaluate immunogenicity and reactogenicity of different COVID-19 vaccines in adults ≥75 already vaccinated against SARS-CoV-2 (EU-COVAT-1-AGED): a trial conducted within the VACCELERATE network
Julia Neuhann, Jannik Stemler, Antonio J. Carcas, et al.
Trials (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 8
The origins of new SARS-COV-2 variants in immunocompromised individuals
Anna C. Riddell, Teresa Cutiño‐Moguel
Current Opinion in HIV and AIDS (2023)
Closed Access | Times Cited: 4
VIPERA: Viral Intra-Patient Evolution Reporting and Analysis
Miguel Álvarez-Herrera, Jordi Sevilla, Paula Ruiz-Rodríguez, et al.
Virus Evolution (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 1
The significance of recurrent de novo amino acid substitutions that emerged during chronic SARS-CoV-2 infection: an observational study
Jonathan Daniel Ip, Wing-Ming Chu, Wan-Mui Chan, et al.
EBioMedicine (2024) Vol. 107, pp. 105273-105273
Open Access | Times Cited: 1
Effectiveness of Sotrovimab in the Omicron Storm Time: A Case Series
Gaetano Cicchitto, Lorena Cardillo, Davide Sequino, et al.
Viruses (2022) Vol. 15, Iss. 1, pp. 102-102
Open Access | Times Cited: 3
COVID-19 vaccines and their impact: An overview
Ka Wa Khong, Ivan Fan‐Ngai Hung
Elsevier eBooks (2024), pp. 379-388
Closed Access
Prolonged SARS-CoV-2 infection successfully treated with a consecutive combined scheme therapy in an HIV- positive patient with AIDS
Alessandra Vergori, Francesco Baldini, Carmela Pinnetti, et al.
Research Square (Research Square) (2023)
Open Access
Risk factors for prolonged viral RNA shedding in patients with COVID-19; a nested case-control study
Yasemin Nadir, Pınar Kıran
The Journal of Infection in Developing Countries (2023) Vol. 17, Iss. 05, pp. 610-616
Open Access
Antiviral treatment or mAbs for persistent SARS‐COV‐2 infection in patients with hematologic malignancies: A case series
Ignacio Pérez Catalán, Iris Gómez‐Alfaro, Sergio García‐Muñoz, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 6
Closed Access
STUDY PROTOCOL A multinational, phase 2, randomised, adaptive protocol to evaluate immunogenicity and reactogenicity of different COVID-19 vaccines in adults ≥75 already vaccinated against SARS-CoV-2 (EU-COVAT-1-AGED): A trial conducted within the VACCELERATE network
Julia Neuhann, Jannik Stemler, Antonio J. Carcas, et al.
Research Square (Research Square) (2022)
Closed Access
Methylprednisolone/mycophenolate mofetil/rituximab

Reactions Weekly (2022) Vol. 1937, Iss. 1, pp. 295-295
Closed Access
Page 1

Scroll to top